Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".
(Updates from 11:12 a.m. ET with closing information.) NEW YORK (
TheStreet) -- Here's what Jim Cramer had to say on
CNBC's "Squawk On The Street" Monday:
Cramer said he likes
Biogen Idec (
BIIB). Deutsche Bank says it's not too late to buy, Cramer said. "The
prescriptions are really unbelievable for its MS drug and I understand that. It makes sense." BIIB closed down 3.1% to $215.73.
Cliffs Natural Resources (
CLF) should be avoided, Cramer said. "People want a cyclical stock so bad. May I suggest
Vale (
VALE)?" CLF was up 5.5% at $21.01.
On Morgan Stanley raising its rating on
UnitedHealth (
UNH), Cramer said the stock has been the "big laggard" in the sector.
Aetna (
AET) has moved ahead,
Humana's (
Hum) moved ahead," Cramer said, adding Morgan's action is "a good call." UNH was 2.2% higher at $60.20.
Cramer said the rap against
Bank of America (
BAC) has been mortgage-related private lawsuits. Now that the bank is starting to get some settlements on these, "You want to buy Bank of America," he advised. BAC rose 5.2% to $12.88 Monday.
Cramer summed up
Groupon (
GRPN) in one word: "Nevermind." GRPN dropped 6.5% to $5.46.
Morgan Stanley changed its rating on
ADT (
ADT) from sell to hold. "Morgan Stanley has targeted this stock, it's the main reason it went down," Cramer said. "They reiterated that they hate it. It has been a complete bow-wow." ADT ended the day 2% higher at $44.36.
To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here. -- Written by Anthony Buccino in New York.
